598 related articles for article (PubMed ID: 16025557)
21. Exploring host factors that impact reovirus replication, dissemination, and reovirus-induced cell death in cancer versus normal cells in culture.
Shmulevitz M; Lee PW
Methods Mol Biol; 2012; 797():163-76. PubMed ID: 21948476
[TBL] [Abstract][Full Text] [Related]
22. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
[TBL] [Abstract][Full Text] [Related]
23. The use of immunohistochemistry to determine oncolytic reovirus distribution and replication in-human tumors.
Kapadia R; Coffey MC
Methods; 2010 Dec; 52(4):301-6. PubMed ID: 20801221
[TBL] [Abstract][Full Text] [Related]
24. Chapter four--Design of improved oncolytic adenoviruses.
Alemany R
Adv Cancer Res; 2012; 115():93-114. PubMed ID: 23021243
[TBL] [Abstract][Full Text] [Related]
25. Combining oncolytic virotherapy and tumour vaccination.
Bridle BW; Hanson S; Lichty BD
Cytokine Growth Factor Rev; 2010; 21(2-3):143-8. PubMed ID: 20226716
[TBL] [Abstract][Full Text] [Related]
26. Viruses - seeking and destroying the tumor program.
O'Shea CC
Oncogene; 2005 Nov; 24(52):7640-55. PubMed ID: 16299526
[TBL] [Abstract][Full Text] [Related]
27. Novel oncolytic viruses: riding high on the next wave?
Stanford MM; Bell JC; Vähä-Koskela MJ
Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409
[TBL] [Abstract][Full Text] [Related]
28. Oncolytic adenoviruses as antiglioma agents.
Jiang H; McCormick F; Lang FF; Gomez-Manzano C; Fueyo J
Expert Rev Anticancer Ther; 2006 May; 6(5):697-708. PubMed ID: 16759161
[TBL] [Abstract][Full Text] [Related]
29. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
30. Naturally occurring viruses for the treatment of cancer.
Roberts MS; Groene WS; Lorence RM; Bamat MK
Discov Med; 2006 Dec; 6(36):217-22. PubMed ID: 17250786
[TBL] [Abstract][Full Text] [Related]
31. Development of transcriptionally regulated oncolytic adenoviruses.
Ko D; Hawkins L; Yu DC
Oncogene; 2005 Nov; 24(52):7763-74. PubMed ID: 16299536
[TBL] [Abstract][Full Text] [Related]
32. [The use of oncolytic adenovirus for the treatment of cancer].
Cascalló M
Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():3-7. PubMed ID: 21381281
[TBL] [Abstract][Full Text] [Related]
33. Development of a second-generation oncolytic Herpes simplex virus expressing TNFalpha for cancer therapy.
Han ZQ; Assenberg M; Liu BL; Wang YB; Simpson G; Thomas S; Coffin RS
J Gene Med; 2007 Feb; 9(2):99-106. PubMed ID: 17256802
[TBL] [Abstract][Full Text] [Related]
34. [Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives].
Sviatchenko VA; Tarasova MV; Netesov SV; Chumakov PM
Mol Biol (Mosk); 2012; 46(4):556-69. PubMed ID: 23113343
[TBL] [Abstract][Full Text] [Related]
35. [Oncolytic viral therapy for cancer therapy].
Shimoyama S; Nakao A
Nihon Rinsho; 2006 Mar; 64(3):589-96. PubMed ID: 16529053
[TBL] [Abstract][Full Text] [Related]
36. New perspectives in cancer virotherapy: bringing the immune system into play.
Boisgerault N; Tangy F; Gregoire M
Immunotherapy; 2010 Mar; 2(2):185-99. PubMed ID: 20635927
[TBL] [Abstract][Full Text] [Related]
37. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
38. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic potential of oncolytic measles virus: promises and challenges.
Galanis E
Clin Pharmacol Ther; 2010 Nov; 88(5):620-5. PubMed ID: 20881957
[TBL] [Abstract][Full Text] [Related]
40. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.
Hasegawa K; Pham L; O'Connor MK; Federspiel MJ; Russell SJ; Peng KW
Clin Cancer Res; 2006 Mar; 12(6):1868-75. PubMed ID: 16551872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
